A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Luckily for you, we built StockStory to help you separate the good from the bad. Keeping that in mind, here are three cash-producing companies to avoid and some better opportunities instead.
Wayfair (W)
Trailing 12-Month Free Cash Flow Margin: 2.9%
Founded in 2002 by Niraj Shah, Wayfair (NYSE: W) is a leading online retailer of mass-market home goods in the US, UK, Canada, and Germany.
Why Is W Not Exciting?
- Struggled with new customer acquisition as its active customers averaged 2.5% declines
- Projected sales growth of 5.2% for the next 12 months suggests sluggish demand
- High servicing costs result in an inferior gross margin of 30.2% that must be offset through higher volumes
Wayfair is trading at $94.20 per share, or 17.5x forward EV/EBITDA. To fully understand why you should be careful with W, check out our full research report (it’s free).
Energy Recovery (ERII)
Trailing 12-Month Free Cash Flow Margin: 19.8%
Having saved far more than a trillion gallons of water, Energy Recovery (NASDAQ: ERII) provides energy recovery devices to the water treatment, oil and gas, and chemical processing sectors.
Why Do We Think Twice About ERII?
- Muted 1.6% annual revenue growth over the last five years shows its demand lagged behind its industrials peers
- Forecasted revenue decline of 32.9% for the upcoming 12 months implies demand will fall off a cliff
- Flat earnings per share over the last five years underperformed the sector average
At $8.86 per share, Energy Recovery trades at 83.7x forward P/E. Dive into our free research report to see why there are better opportunities than ERII.
Inspire Medical Systems (INSP)
Trailing 12-Month Free Cash Flow Margin: 10.6%
Offering an alternative for the millions who struggle with traditional CPAP machines, Inspire Medical Systems (NYSE: INSP) develops and sells an implantable neurostimulation device that treats obstructive sleep apnea by stimulating nerves to keep airways open during sleep.
Why Are We Cautious About INSP?
- Smaller revenue base of $915.2 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Estimated sales decline of 8% for the next 12 months implies a challenging demand environment
Inspire Medical Systems’s stock price of $45.75 implies a valuation ratio of 43.2x forward P/E. If you’re considering INSP for your portfolio, see our FREE research report to learn more.
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
